EPCIS Data Insights

Reporting & Analytics

Smarter Insights at Your Fingertips

Updated on: 04/02/2025

In the world of pharmaceutical logistics and regulatory compliance, data isn’t just important—it’s essential. That’s why we built ATLAS Reports, the latest enhancement to DataX, giving you real-time insights and analysis tools to better understand and act on your EPCIS data.

Whether you're tracking serialized products, validating compliance, or managing operational flows, ATLAS empowers you to access the answers you need—without delay.

What is ATLAS?

ATLAS is DataX’s new reporting environment, designed to bring clarity and visibility to your serialized and logistical data exchanges. The system delivers key metrics, transaction summaries, and partner data access in one easy-to-use interface.

ATLAS Reports appear directly upon login, so users can immediately begin searching, filtering, and analyzing.

Out-of-the-Box Reporting

We’ve included a suite of default reports so you can get started instantly. These include filters for:

GTIN (Global Trade Item Number)
LOT
PO Number
Date & Time
Regulated Product Name

This makes it easy to find the data you need for internal analysis, compliance audits, or external communication—without the need for custom builds.

Partner Visibility Included

We’ve also extended these capabilities to your connected portal partners. Now, downstream partners who access their data through DataX will also benefit from ATLAS Reports. Even if they don’t have a system in place to receive EPCIS, they’ll gain:

Better visibility into received data
Faster compliance response time
Easier identification of anomalies or gaps

It’s full-circle visibility—built right into the exchange.

Custom Reports Available

Need something more specific? Our team can work with you to define and deploy custom reports based on your unique business needs. Whether you’re looking for advanced shipment analysis, event breakdowns, or data mapping, we’ve got you covered.

Early Access Note

ATLAS is in early release. Some reports may include minor errors as we continue to refine the experience. We welcome your feedback as we work toward full production status.